Komori
Shimadzu (7701) · RiskReframed

Risk of Delays in Commercializing New Technologies and Failure to Develop New Products

First written in FY2017. 1 of 2 entries say "Reframed", first in FY2021. Latest entry: FY2021.

2entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY20172017: 120172018: 020182019: 020192020: 020202021: 12021
Same theme, other companies
Risk of Delayed New Product Launches Due to R&D DelaysA theme 72 companies write about · 72 as a headwind · 0 as a tailwind

Shimadzu moved to the "Worse" side of this theme in 2021, 2 years before the typical company in this theme (2023).

The whole theme swung hardest in 2025: 3 of 22 companies on the "Worse" side.

3 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 72 companies compared. The sentences above are computed from all 72.
Full recordFilings, disclosures and news, newest first
  1. FY2021ReframedAnnual report

    「If commercialization is delayed or the company is unable to develop new products that meet market needs, competitiveness may decline and the company may be unable to capture business in line with market trends, potentially reducing future business growth and profitability and affecting the Group's operating performance and financial position.」

    Regarding new product development risk, the impact of declining competitiveness and failure to capture market trends has been explicitly added to the previously identified risks of delays in commercialization and failure to meet market needs.
  2. FY2017First statedAnnual report

    「If commercialization of new technologies is delayed or we are unable to develop new products that meet market needs, future growth and profitability could decline, affecting the Group’s operating results and financial position.」

    The risk of delayed commercialization and inability to develop new products that meet market needs was first stated explicitly despite ongoing R&D investment.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Shimadzu's next results are scheduled for 2026-11-06. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of Delays in Commercializing New Technologies and Failure to Develop New Products | Shimadzu Corporation (7701) | Komori